Zobrazeno 1 - 10
of 79
pro vyhledávání: '"C. Anthony Altar"'
Autor:
Arun K. Tiwari, Clement C. Zai, C. Anthony Altar, Julie-Anne Tanner, Paige E. Davies, Paul Traxler, James Li, Elizabeth S. Cogan, Matthew T. Kucera, Ana Gugila, Nicole Braganza, Heather Emmerson, Gwyneth Zai, Daniel J. Müller, Robert Levitan, Stefan Kloiber, Zafiris J. Daskalakis, Benicio N. Frey, James M. Bowen, Jean-Eric Tarride, Richard Tytus, Ranjith Chandrasena, Nicholas Voudouris, Valerie H. Taylor, Raymond Tempier, Verinder Sharma, Akshya Vasudev, Peter Dzongowski, Lew Pliamm, Todd Greenspoon, Bryan M. Dechairo, James L. Kennedy
Publikováno v:
Translational Psychiatry, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract The pharmacological treatment of depression consists of stages of trial and error, with less than 40% of patients achieving remission during first medication trial. However, in a large, randomized-controlled trial (RCT) in the U.S. (“GUIDE
Externí odkaz:
https://doaj.org/article/40ed16eb2b844f418d55e066132dd8d5
Autor:
Arun K. Tiwari, Clement C. Zai, C. Anthony Altar, Julie-Anne Tanner, Paige E. Davies, Paul Traxler, James Li, Elizabeth S. Cogan, Matthew T. Kucera, Ana Gugila, Nicole Braganza, Heather Emmerson, Gwyneth Zai, Daniel J. Müller, Robert Levitan, Stefan Kloiber, Zafiris J. Daskalakis, Benicio N. Frey, James M. Bowen, Jean-Eric Tarride, Richard Tytus, Ranjith Chandrasena, Nicholas Voudouris, Valerie H. Taylor, Raymond Tempier, Verinder Sharma, Akshya Vasudev, Peter Dzongowski, Lew Pliamm, Todd Greenspoon, Bryan M. Dechairo, James L. Kennedy
Publikováno v:
Translational Psychiatry, Vol 12, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/3cb0eaee71bb4fcaa5ae23651d93735e
Autor:
Stacie Weninger, Bjorn Sperling, Robert Alexander, Magnus Ivarsson, Fiona M. Menzies, Peter Powchik, Christopher J. Weber, C. Anthony Altar, Ronald G. Crystal, Stephen J. Haggarty, Jeanne Loring, Lisa J. Bain, Maria C. Carrillo
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Abstract As knowledge of Alzheimer's disease (AD) progression improves, the field has recognized the need to diversify the pipeline, broaden strategies and approaches to therapies, as well as delivery mechanisms. A better understanding of the earlies
Externí odkaz:
https://doaj.org/article/aad32129c56e420799a40117763c7ff7
Autor:
Wendy R. Galpern, David M. Frim, Stephen B. Tatter, C. Anthony Altar, M. Flint Beal, Ole Isacson
Publikováno v:
Cell Transplantation, Vol 5 (1996)
Brain-derived neurotrophic factor (BDNF) promotes the survival of fetal mesencephalic dopaminergic cells and protects dopaminergic neurons against the toxicity of MPP+ in vitro. Supranigral implantation of fibroblasts genetically engineered to secret
Externí odkaz:
https://doaj.org/article/62b0225114b840b587aade66e16f8464
Publikováno v:
Bioinformatics. 39
Motivation The number of significantly associated regions reported in genome-wide association studies (GWAS) for polygenic traits typically increases with sample size. A traditional tool for quality control and identification of significant regions h
Autor:
Robert Alexander, Lisa J. Bain, Peter Powchik, Maria C. Carrillo, Ronald G. Crystal, Stacie Weninger, Magnus Ivarsson, C. Anthony Altar, Bjorn Sperling, Christopher J. Weber, Fiona M. Menzies, Stephen J. Haggarty, Jeanne F. Loring
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Alzheimer's & Dementia : Translational Research & Clinical Interventions
As knowledge of Alzheimer's disease (AD) progression improves, the field has recognized the need to diversify the pipeline, broaden strategies and approaches to therapies, as well as delivery mechanisms. A better understanding of the earliest biologi
Autor:
Susan Garavaglia, Andrew G Marshak, Seth Goldfarb, Josiah D. Allen, Joseph M Carhart, Joel G. Winner, Kelly K Parsons, Gabriela Lavezzari, C Anthony Altar, Bryan Dechairo
Publikováno v:
Current Medical Research and Opinion. 31:1633-1643
The objective of this project was to determine pharmacy cost savings and improvement in adherence based on a combinatorial pharmacogenomic test (CPGx ) in patients who had switched or added a new psychiatric medication after having failed monotherapy
Autor:
Joel G. Winner, C Anthony Altar, Daniel K. Hall-Flavin, Bryan Dechairo, Josiah D. Allen, Joseph M Carhart
Publikováno v:
Complex Psychiatry. 1:145-155
DNA of 258 patients with treatment-resistant depression was collected in three 8-10 week, two-arm, prospective clinical trials. Forty-four allelic variations were measured in genes for the cytochrome P450 (CYP) enzymes CYP2D6, CYPC19, and CYP1A2, the
Publikováno v:
European Neuropsychopharmacology. 29:S1123
Autor:
David A. Mrazek, Ashwini Shewade, John Hornberger, C. Anthony Altar, Jill Garrison, Victor Cruz
Publikováno v:
International Review of Psychiatry. 25:509-533
Adverse events, response failures and medication non-compliance are common in patients receiving medications for the treatment of mental illnesses. A systematic literature review assessed whether pharmacokinetic (PK) or pharmacodynamic (PD) responses